BHBajaj Healthcare539872Acquisition deal news

NCLT approves acquisition of Genrx Pharmaceuticals on a going concern basis

NCLT, Mumbai Bench, has approved the acquisition of Genrx Pharmaceuticals Private Limited (in Liquidation) on a going concern basis, by order dated October 13, 2026.

By ScoutQuest · Wed 14 Oct 2026, 4:23 PM IST · 2 min read

NCLT Approval Order Date

October 13, 2026

Acquisition Basis

on a going concern basis

Resulting Structure

Genrx Pharmaceuticals will be a Wholly Owned Subsidiary

What the company told the exchanges

• Bajaj Healthcare has informed the exchanges that the Hon'ble National Company Law Tribunal (NCLT), Mumbai Bench, has approved the acquisition of Genrx Pharmaceuticals Private Limited (in Liquidation) on a going concern basis.
• The approval is by an order dated October 13, 2026.
• The company had shared an application before the Tribunal seeking approval for this acquisition.
• The company states this is in continuation of its earlier disclosures dated April 5, 2025 and April 7, 2025 regarding the acquisition of Genrx Pharmaceuticals Private Limited (in Liquidation).

The timeline and validity

• The order was listed on October 13, 2026 and the company downloaded it from the official website of the NCLT on October 13, 2026.
• The order is effective from the date of the order, that is October 13, 2026, until any further order or direction issued by the Tribunal.

What changes on completion

• Genrx Pharmaceuticals Private Limited will be a Wholly Owned Subsidiary of Bajaj Healthcare Limited, subject to the implementation of the terms specified in the NCLT order.
• The company states that it shall take the necessary actions in accordance with the terms of the NCLT order.

What the disclosure records

• In the prescribed format, the company reports no aberrations or non-compliances identified by the authority in the communication.
• It also reports no penalty, restriction or sanction imposed pursuant to the communication.

Trading window

• The trading window for dealing in the securities of Bajaj Healthcare shall continue to remain closed for all Designated Persons, including their immediate relatives, in terms of the company's earlier disclosure dated September 23, 2026.

How a retail investor can read this

• This is a communication from a judicial authority, the NCLT, and the company is reporting its receipt and contents to the exchanges.
• The approval is described as being on a going concern basis, meaning the business of Genrx Pharmaceuticals is being taken over as a running operation rather than being wound up.
• The structural outcome stated by the company is that Genrx Pharmaceuticals will become a wholly owned subsidiary, subject to the terms of the order being implemented.
• The process was already put on record by the company in its earlier disclosures of April 2025; this update marks the Tribunal's approval of that acquisition.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.

About ScoutQuest · Logos provided by Logo.dev